المؤلفون: Webber L., Panay N., Anderson R.A., Nappi R.E., Vincent A.J., Vujovic S., Wolfman W.

مصطلحات الفهرس: ovary tissue, pathophysiology, premature ovarian failure/di [Diagnosis], premature ovarian failure/dt [Drug Therapy], priority journal, psychosocial care, quality of life, reproductive health, review, sexuality, treatment duration, Turner syndrome, venous thromboembolism, wellbeing, biological marker/ec [Endogenous Compound], dexamethasone/cm [Drug Comparison], dexamethasone/po [Oral Drug Administration], dydrogesterone/cb [Drug Combination], dydrogesterone/dt [Drug Therapy], dydrogesterone/po [Oral Drug Administration], estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/po [Oral Drug Administration], estradiol/td [Transdermal Drug Administration], estrogen, gestagen, medroxyprogesterone acetate/dt [Drug Therapy], medroxyprogesterone acetate/po [Oral Drug Administration], norethisterone acetate/cb [Drug Combination], norethisterone acetate/dt [Drug Therapy], norethisterone acetate/po [Oral Drug Administration], norethisterone acetate/td [Transdermal Drug Administration], oral contraceptive agent, placebo, prasterone, progesterone/cb [Drug Combination], progesterone/dt [Drug Therapy], progesterone/po [Oral Drug Administration], female germline stem cell, alternative medicine, androgen therapy, breast cancer, cardiovascular disease, cerebrovascular disease, cognition, contraception, cryopreservation, dementia, female, fertility, fertility preservation, fragile X syndrome, genetics, heredity, hormonal therapy, human, medical society, oocyte donation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29082
Climacteric
Click here for full text options
LibKey Link

المؤلفون: Webber L., Panay N., Anderson R.A., Nappi R.E., Vincent A.J., Vujovic S., Wolfman W.

مصطلحات الفهرس: ovary tissue, pathophysiology, premature ovarian failure/di [Diagnosis], premature ovarian failure/dt [Drug Therapy], priority journal, psychosocial care, quality of life, reproductive health, review, sexuality, treatment duration, Turner syndrome, venous thromboembolism, wellbeing, biological marker/ec [Endogenous Compound], dexamethasone/cm [Drug Comparison], dexamethasone/po [Oral Drug Administration], dydrogesterone/cb [Drug Combination], dydrogesterone/dt [Drug Therapy], dydrogesterone/po [Oral Drug Administration], estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/po [Oral Drug Administration], estradiol/td [Transdermal Drug Administration], estrogen, gestagen, medroxyprogesterone acetate/dt [Drug Therapy], medroxyprogesterone acetate/po [Oral Drug Administration], norethisterone acetate/cb [Drug Combination], norethisterone acetate/dt [Drug Therapy], norethisterone acetate/po [Oral Drug Administration], norethisterone acetate/td [Transdermal Drug Administration], oral contraceptive agent, placebo, prasterone, progesterone/cb [Drug Combination], progesterone/dt [Drug Therapy], progesterone/po [Oral Drug Administration], female germline stem cell, alternative medicine, androgen therapy, breast cancer, cardiovascular disease, cerebrovascular disease, cognition, contraception, cryopreservation, dementia, female, fertility, fertility preservation, fragile X syndrome, genetics, heredity, hormonal therapy, human, medical society, oocyte donation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29082
Climacteric
LibKey Link

المؤلفون: Shah S., Vincent A.J., Nguyen H.H.

مصطلحات الفهرس: female, fracture, gonadal dysgenesis, hormone substitution, human, patient care, practice guideline, priority journal, puberty, review, Turner syndrome/di [Diagnosis], Turner syndrome/dt [Drug Therapy], estradiol/dt [Drug Therapy], pregnancy, adult, cardiovascular disease, clinical feature, distress syndrome, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36979
Climacteric
Click here for full text options
LibKey Link

المؤلفون: Shah S., Vincent A.J., Nguyen H.H.

مصطلحات الفهرس: female, fracture, gonadal dysgenesis, hormone substitution, human, patient care, practice guideline, priority journal, puberty, review, Turner syndrome/di [Diagnosis], Turner syndrome/dt [Drug Therapy], estradiol/dt [Drug Therapy], pregnancy, adult, cardiovascular disease, clinical feature, distress syndrome, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36979
Climacteric
Click here for full text options
LibKey Link

المؤلفون: Hill R.A., Du X.

مصطلحات الفهرس: nonhuman, prospective study, risk factor, signal transduction, treatment indication, 7,8 dihydroxyflavone/dt [Drug Therapy], abrineurin/dt [Drug Therapy], anastrozole, androstanolone, antidepressant agent, brain derived neurotrophic factor/ec [Endogenous Compound], donepezil, estradiol/dt [Drug Therapy], estradiol/ec [Endogenous Compound], estrogen, placebo, raloxifene, selective estrogen receptor modulator/dt [Drug Therapy], sex hormone/ec [Endogenous Compound], testosterone/dt [Drug Therapy], testosterone/ec [Endogenous Compound], testosterone blood level, Alzheimer disease, article, basic research, blood brain barrier, clinical research, clinical trial (topic), cognition, cognitive defect, dementia/dt [Drug Therapy], drug efficacy, estradiol blood level, evidence based medicine, hormonal therapy, human, Article

URL: Journal of Molecular Neuroscience
Click here for full text options
LibKey Link

المؤلفون: Hill R.A., Du X.

مصطلحات الفهرس: nonhuman, prospective study, risk factor, signal transduction, treatment indication, 7,8 dihydroxyflavone/dt [Drug Therapy], abrineurin/dt [Drug Therapy], anastrozole, androstanolone, antidepressant agent, brain derived neurotrophic factor/ec [Endogenous Compound], donepezil, estradiol/dt [Drug Therapy], estradiol/ec [Endogenous Compound], estrogen, placebo, raloxifene, selective estrogen receptor modulator/dt [Drug Therapy], sex hormone/ec [Endogenous Compound], testosterone/dt [Drug Therapy], testosterone/ec [Endogenous Compound], testosterone blood level, Alzheimer disease, article, basic research, blood brain barrier, clinical research, clinical trial (topic), cognition, cognitive defect, dementia/dt [Drug Therapy], drug efficacy, estradiol blood level, evidence based medicine, hormonal therapy, human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40481
Journal of Molecular Neuroscience
LibKey Link

المؤلفون: Rachon D., Teede H.

مصطلحات الفهرس: disease predisposition, drug use, health practitioner, hormone substitution, human, incidence, monotherapy, obesity, pathogenesis, patient compliance, postmenopause osteoporosis/dt [Drug Therapy], practice guideline, prescription, priority journal, review, risk assessment, risk benefit analysis, side effect/si [Side Effect], venous thromboembolism/si [Side Effect], venous thromboembolism/ep [Epidemiology], venous thromboembolism/et [Etiology], women's health, acetylsalicylic acid, blood clotting factor 5 Leiden/ec [Endogenous Compound], conjugated estrogen/ae [Adverse Drug Reaction], conjugated estrogen/ct [Clinical Trial], conjugated estrogen/cb [Drug Combination], conjugated estrogen/dt [Drug Therapy], conjugated estrogen/po [Oral Drug Administration], cyproterone/ae [Adverse Drug Reaction], dydrogesterone/ae [Adverse Drug Reaction], estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/po [Oral Drug Administration], estradiol/td [Transdermal Drug Administration], estrogen/pa [Parenteral Drug Administration], estrogen/td [Transdermal Drug Administration], gestagen/cb [Drug Combination], gestagen/dt [Drug Therapy], gestagen/po [Oral Drug Administration], hydroxymethylglutaryl coenzyme A reductase inhibitor, medroxyprogesterone acetate/ae [Adverse Drug Reaction], medroxyprogesterone acetate/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/dt [Drug Therapy], medroxyprogesterone acetate/po [Oral Drug Administration], nomegestrol/ae [Adverse Drug Reaction], norethisterone/td [Transdermal Drug Administration], norethisterone acetate/cb [Drug Combination], norethisterone acetate/dt [Drug Therapy], norethisterone acetate/po [Oral Drug Administration], placebo, progesterone/cb [Drug Combination], progesterone derivative/dt [Drug Therapy], promegestone/ae [Adverse Drug Reaction], raloxifene/ae [Adverse Drug Reaction], raloxifene/ct [Clinical Trial], raloxifene/dt [Drug Therapy], selective estrogen receptor modulator/ae [Adverse Drug Reaction], tibolone/ae [Adverse Drug Reaction], tibolone/ct [Clinical Trial], tibolone/dt [Drug Therapy], tibolone/po [Oral Drug Administration], menopausal syndrome/dt [Drug Therapy], estrogen/ae [Adverse Drug Reaction], estrogen/ct [Clinical Trial], estrogen/ad [Drug Administration], estrogen/cb [Drug Combination], estrogen/dt [Drug Therapy], estrogen/po [Oral Drug Administration], selective estrogen receptor modulator/ct [Clinical Trial], selective estrogen receptor modulator/dt [Drug Therapy], age distribution, body mass, cardiovascular risk, clinical trial, combination chemotherapy, disease association, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31685
Click here for full text options
LibKey Link

المؤلفون: Copolov D., Kulkarni J., De Castella A., Smith D., Taffe J., Keks N.

مصطلحات الفهرس: clinical article, clinical trial, controlled clinical trial, controlled study, female, human, schizophrenia/dt [Drug Therapy], benzodiazepine/dt [Drug Therapy], chlorpromazine/dt [Drug Therapy], estradiol/ct [Clinical Trial], estradiol/dt [Drug Therapy], estrogen/ct [Clinical Trial], estrogen/dt [Drug Therapy], haloperidol/dt [Drug Therapy], neuroleptic agent/dt [Drug Therapy], thioridazine/dt [Drug Therapy], trifluoperazine/dt [Drug Therapy], priority journal, adult, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33981
Click here for full text options
LibKey Link

المؤلفون: Teede H.J.

مصطلحات الفهرس: human, ischemic heart disease, lipid metabolism, review, risk assessment, risk factor, short course therapy, vein thrombosis/pc [Prevention], conjugated estrogen/ct [Clinical Trial], conjugated estrogen/cb [Drug Combination], conjugated estrogen/dt [Drug Therapy], conjugated estrogen/pd [Pharmacology], estradiol/ct [Clinical Trial], estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/po [Oral Drug Administration], estradiol/pd [Pharmacology], estrogen/ct [Clinical Trial], estrogen/dt [Drug Therapy], estrogen/pd [Pharmacology], gestagen/ct [Clinical Trial], gestagen/cb [Drug Combination], gestagen/dt [Drug Therapy], gestagen/pd [Pharmacology], gestodene/ct [Clinical Trial], gestodene/cb [Drug Combination], gestodene/dt [Drug Therapy], gestodene/pd [Pharmacology], medroxyprogesterone acetate/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/dt [Drug Therapy], medroxyprogesterone acetate/pd [Pharmacology], placebo, progesterone/dt [Drug Therapy], progesterone/pd [Pharmacology], raloxifene/ct [Clinical Trial], raloxifene/cb [Drug Combination], raloxifene/dt [Drug Therapy], tibolone/dt [Drug Therapy], tibolone/pd [Pharmacology], heart protection, atherosclerosis/dt [Drug Therapy], atherosclerosis/pc [Prevention], blood pressure, blood vessel reactivity, blood vessel tone, breast cancer, cardiovascular disease/dt [Drug Therapy], cardiovascular disease/pc [Prevention], cerebrovascular disease/dt [Drug Therapy], cerebrovascular disease/pc [Prevention], clinical trial, drug effect, hormone substitution, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32703
Click here for full text options
LibKey Link

المؤلفون: Anderson D.C., Robertson W.R., Critchley H.O.D., Buckley C.H.

مصطلحات الفهرس: estradiol/pd [Pharmacology], estrogen receptor, progesterone/dt [Drug Therapy], progesterone/pd [Pharmacology], ovulation induction, article, clinical article, controlled study, endometrium, epithelium, female, human, human tissue, immunohistochemistry, intravaginal drug administration, ovary insufficiency/dt [Drug Therapy], quantitative histochemistry, stroma cell, transdermal drug administration, antigen/ec [Endogenous Compound], estradiol/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34479
Click here for full text options
LibKey Link

المؤلفون: De Castella A.R., Burger H., Riedel A., Rolfe T.J., Fitzgerald P.B., Taffe J., Kulkarni J.

مصطلحات الفهرس: neuroprotection, priority journal, rating scale, receptor density, hormonal regulation, liver microsome, menstrual cycle, clinical article, clinical trial, dose calculation, double blind procedure, drug effect, estrogen blood level, estrogen therapy, female, human, schizophrenia/dt [Drug Therapy], dopamine, estradiol/do [Drug Dose], estradiol/dt [Drug Therapy], estradiol/td [Transdermal Drug Administration], estrogen/ct [Clinical Trial], estrogen/do [Drug Dose], estrogen/dt [Drug Therapy], estrogen/pd [Pharmacology], estrogen/td [Transdermal Drug Administration], ethinylestradiol/do [Drug Dose], ethinylestradiol/po [Oral Drug Administration], placebo, prolactin, serotonin, adult, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33047
Click here for full text options
LibKey Link

المؤلفون: Yap D., Farrell E.

مصطلحات الفهرس: menopausal syndrome/dt [Drug Therapy], menopausal syndrome/et [Etiology], osteolysis, patient counseling, patient referral, prescription, risk benefit analysis, side effect/si [Side Effect], thromboembolism/si [Side Effect], transdermal patch, treatment indication, clonidine/ae [Adverse Drug Reaction], clonidine/cm [Drug Comparison], clonidine/dt [Drug Therapy], clonidine/pd [Pharmacology], conjugated estrogen/ae [Adverse Drug Reaction], conjugated estrogen/ct [Clinical Trial], conjugated estrogen/cb [Drug Combination], conjugated estrogen/cm [Drug Comparison], conjugated estrogen/dt [Drug Therapy], conjugated estrogen/po [Oral Drug Administration], conjugated estrogen/pr [Pharmaceutics], conjugated estrogen plus medroxyprogesterone acetate/ae [Adverse Drug Reaction], conjugated estrogen plus medroxyprogesterone acetate/ct [Clinical Trial], conjugated estrogen plus medroxyprogesterone acetate/ad [Drug Administration], conjugated estrogen plus medroxyprogesterone acetate/cm [Drug Comparison], conjugated estrogen plus medroxyprogesterone acetate/dt [Drug Therapy], conjugated estrogen plus medroxyprogesterone acetate/po [Oral Drug Administration], conjugated estrogen plus medroxyprogesterone acetate/pr [Pharmaceutics], cyproterone acetate/ae [Adverse Drug Reaction], cyproterone acetate/cb [Drug Combination], cyproterone acetate/dt [Drug Therapy], cyproterone acetate/po [Oral Drug Administration], cyproterone acetate/pr [Pharmaceutics], cyproterone acetate plus estradiol valerate, dydrogesterone/ae [Adverse Drug Reaction], dydrogesterone/cb [Drug Combination], dydrogesterone/dt [Drug Therapy], dydrogesterone/po [Oral Drug Administration], dydrogesterone/pr [Pharmaceutics], dydrogesterone plus estradiol, estradiol/ae [Adverse Drug Reaction], estradiol/ad [Drug Administration], estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/po [Oral Drug Administration], estradiol/pr [Pharmaceutics], estradiol/td [Transdermal Drug Administration], estradiol plus norethisterone acetate/ae [Adverse Drug Reaction], estradiol plus norethisterone acetate/ad [Drug Administration], estradiol plus norethisterone acetate/dt [Drug Therapy], estradiol plus norethisterone acetate/pr [Pharmaceutics], estradiol plus norethisterone acetate/td [Transdermal Drug Administration], estradiol valerate/ae [Adverse Drug Reaction], estradiol valerate/cb [Drug Combination], estradiol valerate/dt [Drug Therapy], estradiol valerate/po [Oral Drug Administration], estradiol valerate/pr [Pharmaceutics], estrofem, estrogen derivative/ae [Adverse Drug Reaction], estrogen derivative/ct [Clinical Trial], estrogen derivative/ad [Drug Administration], estrogen derivative/cb [Drug Combination], estrogen derivative/cm [Drug Comparison], estrogen derivative/dt [Drug Therapy], estrogen derivative/na [Intranasal Drug Administration], estrogen derivative/va [Intravaginal Drug Administration], estrogen derivative/po [Oral Drug Administration], estrogen derivative/pr [Pharmaceutics], estrogen derivative/td [Transdermal Drug Administration], medroxyprogesterone acetate/ae [Adverse Drug Reaction], medroxyprogesterone acetate/ct [Clinical Trial], medroxyprogesterone acetate/ad [Drug Administration], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/dt [Drug Therapy], medroxyprogesterone acetate/na [Intranasal Drug Administration], medroxyprogesterone acetate/va [Intravaginal Drug Administration], medroxyprogesterone acetate/po [Oral Drug Administration], medroxyprogesterone acetate/pr [Pharmaceutics], medroxyprogesterone acetate/td [Transdermal Drug Administration], norethisterone/ae [Adverse Drug Reaction], norethisterone/dt [Drug Therapy], norethisterone/po [Oral Drug Administration], norethisterone/pr [Pharmaceutics], phytoestrogen/dt [Drug Therapy], phytoestrogen/pk [Pharmacokinetics], piperazine estrone sulfate, progesterone/dt [Drug Therapy], progesterone/ec [Endogenous Compound], progesterone/pr [Pharmaceutics], progesterone derivative/ae [Adverse Drug Reaction], progesterone derivative/ct [Clinical Trial], progesterone derivative/ad [Drug Administration], progesterone derivative/cb [Drug Combination], progesterone derivative/cm [Drug Comparison], progesterone derivative/dt [Drug Therapy], progesterone derivative/na [Intranasal Drug Administration], progesterone derivative/va [Intravaginal Drug Administration], progesterone derivative/po [Oral Drug Administration], progesterone derivative/pr [Pharmaceutics], progesterone derivative/td [Transdermal Drug Administration], propranolol/cm [Drug Comparison], propranolol/dt [Drug Therapy], propranolol/pd [Pharmacology], serotonin uptake inhibitor/dt [Drug Therapy], serotonin uptake inhibitor/pd [Pharmacology], testosterone/ad [Drug Administration], testosterone/cb [Drug Combination], testosterone/dt [Drug Therapy], testosterone/ec [Endogenous Compound], testosterone/po [Oral Drug Administration], testosterone/td [Transdermal Drug Administration], tibolone/cm [Drug Comparison], tibolone/dt [Drug Therapy], tibolone/pk [Pharmacokinetics], tibolone/pd [Pharmacology], trisequens, unclassified drug, venlafaxine/dt [Drug Therapy], venlafaxine/pd [Pharmacology], andro feme cream, catapress 100, climen 28, cyprone, estalis continuous, estracombi, Estraderm MX, femtran, genoral, kliovance, menoprem continuous, natragen cream, oestradiol implants, ovestin tablets, piperazone estrone sulfate/ae [Adverse Drug Reaction], piperazone estrone sulfate/dt [Drug Therapy], piperazone estrone sulfate/po [Oral Drug Administration], piperazone estrone sulfate/pr [Pharmaceutics], premia, premia continuous, pro feme cream, procur, provelle 28, ralovera, medroxyhexal, article, breast cancer/di [Diagnosis], breast cancer/si [Side Effect], cardiovascular disease/dt [Drug Therapy], cardiovascular disease/pc [Prevention], clinical feature, clinical trial, deep vein thrombosis/si [Side Effect], drug absorption, drug efficacy, drug formulation, hormone substitution, human, lifestyle, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33104
Click here for full text options
LibKey Link

المؤلفون: Farrell E., Palmer D.

مصطلحات الفهرس: cyproterone/dt [Drug Therapy], cyproterone acetate, dydrogesterone/dt [Drug Therapy], estradiol/dt [Drug Therapy], estradiol valerate/dt [Drug Therapy], estriol/dt [Drug Therapy], estrogen/dt [Drug Therapy], gestagen/dt [Drug Therapy], levonorgestrel/dt [Drug Therapy], medroxyprogesterone acetate/dt [Drug Therapy], mestranol plus norethisterone, norethisterone/dt [Drug Therapy], piperazine estrone sulfate/dt [Drug Therapy], testosterone/dt [Drug Therapy], trisequens, bone density, clinical feature, female, hormone substitution, human, menopausal syndrome/dt [Drug Therapy], menopausal syndrome/pc [Prevention], menopause, osteoporosis/dt [Drug Therapy], osteoporosis/pc [Prevention], risk benefit analysis, short survey, conjugated estrogen/dt [Drug Therapy], Short Survey

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34426
Click here for full text options
LibKey Link

المؤلفون: O'Connor D.W., Hall K.A., Keks N.A.

مصطلحات الفهرس: hospital patient, human, male, Mini Mental State Examination, nursing home, peripheral edema/si [Side Effect], physical examination, randomized controlled trial, rating scale, rebound, testosterone blood level, thrombophlebitis/si [Side Effect], treatment outcome, benzodiazepine/dt [Drug Therapy], estradiol/ae [Adverse Drug Reaction], estradiol/ct [Clinical Trial], estradiol/cr [Drug Concentration], estradiol/dt [Drug Therapy], estradiol/td [Transdermal Drug Administration], estrogen/ae [Adverse Drug Reaction], estrogen/ct [Clinical Trial], estrogen/cr [Drug Concentration], estrogen/dt [Drug Therapy], estrogen/td [Transdermal Drug Administration], psychotropic agent/dt [Drug Therapy], testosterone/ec [Endogenous Compound], dementia, adult, aged, aggression, article, behavior disorder/dt [Drug Therapy], clinical article, clinical trial, controlled clinical trial, controlled study, disease course, drug efficacy, drug tolerability, estrogen blood level, geriatric patient, gynecomastia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32253
Click here for full text options
LibKey Link

المؤلفون: Gargett C., Healy D.

مصطلحات الفهرس: female genital tract malformation/su [Surgery], female infertility/th [Therapy], fertilization in vitro, fibroblast, genotype, hematopoietic stem cell transplantation, homeostasis, hormonal regulation, hormone blood level, human, hysteroscopy, intrauterine contraceptive device, menstrual cycle, menstruation, mesenchymal stem cell, mononuclear cell, multiple cycle treatment, pregnancy, premature ovarian failure, puerperium, review, spontaneous abortion, stem cell, tissue adhesion, tissue regeneration, uterus blood flow, uterus synechia/dt [Drug Therapy], uterus synechia/th [Therapy], wound healing, CD133 antigen/ec [Endogenous Compound], CD33 antigen/ec [Endogenous Compound], CD34 antigen/ec [Endogenous Compound], CD9 antigen/ec [Endogenous Compound], chorionic gonadotropin beta subunit/ec [Endogenous Compound], estradiol/dt [Drug Therapy], estradiol valerate/do [Drug Dose], estradiol valerate/dt [Drug Therapy], estrogen/ec [Endogenous Compound], progesterone/dt [Drug Therapy], sex hormone/ec [Endogenous Compound], Thy 1 antigen/ec [Endogenous Compound], vasculotropin receptor 2/ec [Endogenous Compound], endometrial stem cell, endometrium adhesion/su [Surgery], endometrium regeneration, intrauterine adhesion, uterus cavity, amenorrhea, antigen expression, apoptosis, autologous bone marrow transplantation, balloon catheter, color ultrasound flowmetry, curettage, decidualization, disease severity, Doppler echography, drug megadose, embryo transfer, endometrial disease, epithelium cell, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30290
Click here for full text options
LibKey Link

المؤلفون: Peverill R.E.

مصطلحات الفهرس: venous thromboembolism, activated protein C/ec [Endogenous Compound], anticoagulant agent, blood clotting factor 5 Leiden/ec [Endogenous Compound], blood clotting factor 7/ec [Endogenous Compound], conjugated estrogen/ct [Clinical Trial], conjugated estrogen/cb [Drug Combination], conjugated estrogen/dt [Drug Therapy], conjugated estrogen/po [Oral Drug Administration], estradiol/ct [Clinical Trial], estradiol/dt [Drug Therapy], estrogen/ct [Clinical Trial], estrogen/cb [Drug Combination], estrogen/do [Drug Dose], estrogen/dt [Drug Therapy], estrogen/po [Oral Drug Administration], estrogen/td [Transdermal Drug Administration], fibrin/ec [Endogenous Compound], gestagen/ct [Clinical Trial], gestagen/cb [Drug Combination], gestagen/do [Drug Dose], gestagen/dt [Drug Therapy], gestagen/po [Oral Drug Administration], gestagen/td [Transdermal Drug Administration], medroxyprogesterone acetate/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/dt [Drug Therapy], norethisterone/ct [Clinical Trial], norethisterone/dt [Drug Therapy], raloxifene/dt [Drug Therapy], tamoxifen/dt [Drug Therapy], thrombin/ec [Endogenous Compound], tibolone/dt [Drug Therapy], selective estrogen receptor modulator/dt [Drug Therapy], activated protein C resistance, clinical trial, fibrinolysis, high risk population, hormone substitution, human, menopausal syndrome/dt [Drug Therapy], meta analysis, review, risk assessment, risk factor, systematic review, thrombophilia, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32700
Click here for full text options
LibKey Link

المؤلفون: Farrell E.

مصطلحات الفهرس: headache/dt [Drug Therapy], hormonal therapy, hot flush/dt [Drug Therapy], human, irritability, libido, lifestyle, long term care, menopausal syndrome/dt [Drug Therapy], menopausal syndrome/th [Therapy], menopause, mood disorder/si [Side Effect], musculoskeletal disease/dt [Drug Therapy], nausea/si [Side Effect], night sweat/dt [Drug Therapy], nutrition, osteoporosis/dt [Drug Therapy], osteoporosis/pc [Prevention], periodontal disease/dt [Drug Therapy], review, risk assessment, side effect/si [Side Effect], smoking, treatment contraindication, treatment indication, urogenital tract disease/dt [Drug Therapy], calcium, clonidine/dt [Drug Therapy], dydrogesterone/dt [Drug Therapy], estradiol/dt [Drug Therapy], estriol/dt [Drug Therapy], estrogen/ae [Adverse Drug Reaction], estrogen/bd [Buccal Drug Administration], estrogen/ad [Drug Administration], estrogen/cb [Drug Combination], estrogen/dt [Drug Therapy], estrogen/im [Intramuscular Drug Administration], estrogen/na [Intranasal Drug Administration], estrogen/ut [Intrauterine Drug Administration], estrogen/va [Intravaginal Drug Administration], estrogen/po [Oral Drug Administration], estrogen/sc [Subcutaneous Drug Administration], estrogen/td [Transdermal Drug Administration], estrone/dt [Drug Therapy], gestagen/ae [Adverse Drug Reaction], gestagen/bd [Buccal Drug Administration], gestagen/ad [Drug Administration], gestagen/cb [Drug Combination], gestagen/dt [Drug Therapy], gestagen/im [Intramuscular Drug Administration], gestagen/na [Intranasal Drug Administration], gestagen/ut [Intrauterine Drug Administration], gestagen/va [Intravaginal Drug Administration], gestagen/po [Oral Drug Administration], gestagen/sc [Subcutaneous Drug Administration], gestagen/td [Transdermal Drug Administration], levonorgestrel/dt [Drug Therapy], medroxyprogesterone acetate/dt [Drug Therapy], norethisterone/dt [Drug Therapy], phytoestrogen, progesterone/dt [Drug Therapy], serotonin uptake inhibitor/dt [Drug Therapy], testosterone/bd [Buccal Drug Administration], testosterone/ad [Drug Administration], testosterone/dt [Drug Therapy], testosterone/im [Intramuscular Drug Administration], testosterone/na [Intranasal Drug Administration], testosterone/ut [Intrauterine Drug Administration], testosterone/va [Intravaginal Drug Administration], testosterone/po [Oral Drug Administration], testosterone/cj [Subconjunctival Drug Administration], testosterone/td [Transdermal Drug Administration], tibolone/dt [Drug Therapy], mood disorder/dt [Drug Therapy], alcohol consumption, alternative medicine, breakthrough bleeding/si [Side Effect], breast cancer, breast disease/si [Side Effect], cancer risk, cognitive defect/dt [Drug Therapy], dementia/dt [Drug Therapy], diabetes mellitus, diet, endometriosis, exercise, fluid retention, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32701
Click here for full text options
LibKey Link

المؤلفون: Kaitu'u-Lino T.J., Morison N.B., Salamonsen L.A., Fraser I.S.

مصطلحات الفهرس: uterus bleeding/pc [Prevention], mifepristone/cb [Drug Combination], mifepristone/do [Drug Dose], mifepristone/dt [Drug Therapy], mifepristone/pd [Pharmacology], mifepristone/sc [Subcutaneous Drug Administration], progesterone receptor/ec [Endogenous Compound], animal cell, animal experiment, animal model, animal tissue, article, bleeding, breakthrough bleeding/dt [Drug Therapy], breakthrough bleeding/pc [Prevention], cell proliferation, cellular distribution, controlled study, decidua, decidualization, drug exposure, drug mechanism, endometrium, female, immunohistochemistry, long term exposure, mouse, nonhuman, priority journal, pseudopregnancy, risk reduction, single drug dose, tissue repair, uterus bleeding/dt [Drug Therapy], contraceptive agent, estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/pd [Pharmacology], estrogen receptor/ec [Endogenous Compound], etonogestrel/to [Drug Toxicity], etonogestrel/sc [Subcutaneous Drug Administration], gestagen, Ki 67 antigen, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31593
Click here for full text options
LibKey Link

المؤلفون: Smolich J.J., Davis S.R., Goldstat R., Peverill R.E., Malan E.

مصطلحات الفهرس: statistical significance, thrombocyte, thrombocyte activation, estradiol/dt [Drug Therapy], estradiol plus norethisterone acetate/cm [Drug Comparison], estradiol plus norethisterone acetate/do [Drug Dose], estradiol plus norethisterone acetate/dt [Drug Therapy], estradiol plus norethisterone acetate/po [Oral Drug Administration], lipid, norethisterone acetate/dt [Drug Therapy], PADGEM protein/ec [Endogenous Compound], pravastatin/cm [Drug Comparison], pravastatin/dt [Drug Therapy], protein expression, adult, article, blood level, cardiovascular system, clinical trial, controlled clinical trial, controlled study, double blind procedure, female, hormonal therapy, human, hypercholesterolemia/dt [Drug Therapy], low drug dose, major clinical study, postmenopause, aged, randomized controlled trial, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32053
Click here for full text options
LibKey Link

المؤلفون: Zoungas S., Kotsopoulos D., Liang Y.-L., Teede H.J., McGrath B.P., Craven R.

مصطلحات الفهرس: postmenopause/dt [Drug Therapy], progesterone/cb [Drug Combination], progesterone/dt [Drug Therapy], progesterone/pd [Pharmacology], triacylglycerol/ec [Endogenous Compound], artery dilatation, artery endothelium, article, cardiovascular effect, clinical trial, controlled clinical trial, controlled study, double blind procedure, estrogen activity, female, hormone substitution, human, long term care, major clinical study, placebo, priority journal, pulse wave, randomized controlled trial, treatment outcome, estradiol/cb [Drug Combination], estradiol/dt [Drug Therapy], estradiol/po [Oral Drug Administration], estradiol/pd [Pharmacology], estradiol plus norethisterone acetate, estrogen/cb [Drug Combination], estrogen/dt [Drug Therapy], estrogen/po [Oral Drug Administration], estrogen/pd [Pharmacology], high density lipoprotein/ec [Endogenous Compound], lipoprotein A/ec [Endogenous Compound], low density lipoprotein/ec [Endogenous Compound], norethisterone/cb [Drug Combination], norethisterone/dt [Drug Therapy], norethisterone/pd [Pharmacology], adult, artery compliance, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33227
Click here for full text options
LibKey Link